FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine and pharmacology, and concerns application of 3-(1-methyl-1H-indole-3-yl)-4-[1-{(1-pyridine-2-ylmethyl)piperidine-4-yl}-1H-indole-3-yl]pyrrole-2,5-dione or 3-(1-methyl-1H-indole-3-yl)-4-[1-( piperidine-4-yl)-1H-indole-3-yl]pyrrole-2,5-dione.
EFFECT: offered is a pharmaceutical composition for high-efficient treatment and prevention of organ or tissue graft rejection.
4 cl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| USING PKC INHIBITORS IN TRANSPLANTATION | 2007 |
|
RU2494738C2 |
| PHARMACEUTICAL COMBINATIONS CONTAINING PYRIDO[4,3-d]PYRIMIDINE DERIVATIVES AS HSP90 INHIBITOR AND HER2 INHIBITOR | 2009 |
|
RU2532375C2 |
| METHODS AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTIONS | 2012 |
|
RU2665021C2 |
| METHODS AND COMPOSITIONS TO IMPROVE COGNITIVE FUNCTIONS | 2012 |
|
RU2792010C2 |
| LYSIN-SPECIFIC DEMETHYLASE-1 INHIBITORS AND USE THEREOF | 2011 |
|
RU2599248C2 |
| 2,4-SUBSTITUTED INDOLES AND PHARMECEUTICAL MIXTURE WITH ANTAGONISTIC ACTIVITY TO "5-ГТ6" RECEPTOR | 2003 |
|
RU2326112C2 |
| LYSIN-SPECIFIC DEMETHYLASE-1 INHIBITORS AND USE THEREOF | 2010 |
|
RU2602814C2 |
| INDOLYLMALEIMIDE DERIVATIVES AS PROTEIN KINASE C (PKC) INHIBITORS | 2005 |
|
RU2372348C2 |
| 2,7-SUBSTITUTED INDOLES AND PHARMACEUTICAL COMPOSITION, WITH ANTAGONIST ACTIVITY TO К 5-ГТ6 RECEPTOR | 2003 |
|
RU2327685C2 |
| SUBSTITUTED INDOLES, ANTIVIRAL ACTIVE COMPONENT, SYNTHESIS AND APPLICATION METHOD | 2010 |
|
RU2436786C1 |
